The Journal of Pain
Volume 8, Issue 7 , Pages 573-582 , July 2007

Substance Use Disorders in a Primary Care Sample Receiving Daily Opioid Therapy

  • Michael F. Fleming

      Affiliations

    • Department of Family Medicine, University of Wisconsin, Madison, Wisconsin.
    • Corresponding Author InformationAddress reprint requests to Dr. Michael Fleming, Department of Family Medicine, University of Wisconsin, Madison, 777 S. Mills Street, Madison, WI 53715.
    • ,
  • Stacey L. Balousek

      Affiliations

    • Department of Family Medicine, University of Wisconsin, Madison, Wisconsin.
    • ,
  • Cynthia L. Klessig

      Affiliations

    • Department of Family Medicine, University of Wisconsin, Madison, Wisconsin.
    • ,
  • Marlon P. Mundt

      Affiliations

    • Department of Family Medicine, University of Wisconsin, Madison, Wisconsin.
    • ,
  • David D. Brown

      Affiliations

    • University of British Columbia, Vancouver, British Columbia, Canada.

Received 6 July 2006 ,Revised 20 February 2007 ,Accepted 27 February 2007.

References 

  1. Ackini I, Tartar R, Kirisci H. Concordance between verbal report and urine screen of recent marijuana use in adolescents. Addict Behav. 2001;25:613–619
  2. American Pain Society. Definitions related to the use of opioids for the treatment of pain: A consensus document from the American Academy of Pain Medicine, the American Pain Society and the American Society of Addiction Medicine. 2001;
  3. Ballantyne J, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943–1953
  4. Brookoff D. Chronic pain: A new disease?. Hosp Pract (Minneapolis). 2000;35:45–52
  5. Chelminski P, Ives T, Felix K, Prakken S, Miller T, Perhac J, et al. A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Serv Res. 2005;5:3
  6. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and ‘problematic’ substance use: Evaluation of a pilot assessment tool. J Pain Sympt Manage. 1998;16:355–363
  7. Cowan D, Wilson-Barnett J, Griffiths P, Allan L. A survey of chronic non-cancer pain patients prescribed opioid analgesics. Pain Med. 2003;4:340–351
  8. Diamond S, Freitag F, Solomon G, Millstein E. Migraine headache: Working for the best outcome. Postgrad Med. 1987;81:L174–L176
  9. Fishbain D, Rosomoff H, Rosomoff R. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77–85
  10. Gureje O, Von Korff M, Simon G, Gater R. Persistent pain and well being: A world Health Organization Study in Primary Care. JAMA. 1998;280:147–151
  11. Martell B, O’Connor P, Kerns R, Becker W, Morales K. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy and association with addiction. Ann Intern Med. 2007;146:116–127
  12. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. J Substance Abuse Treat. 1992;9:199–213
  13. McQuay H. Opioids in pain management. Lancet. 1999;353:2229–2232
  14. Miele G, Carpenter K, Smith Cockerham M, Dietz Trautman K, Blaine J, Hasin D. Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS). Drug Alcohol Depend. 2000;59:77–88
  15. Novak S, Nemeth W, Lawson K. Trends in medical use and abuse of sustained-release opioid analgesics: A revisit. Pain Med. 2004;5:59–65
  16. Passik S, Kirsh K. Assessing aberrant drug taking behaviors in the patient with chronic pain. Curr Pain Headache Rep. 2004;8:289–294
  17. Passik S, Kirsh K, Whitcomb L, Dickerson P, Theobald DE. Pain clinicians’ rankings of aberrant drug-taking behaviors. J Pain Palliat Care Pharmacother. 2002;16:39–49
  18. Perry S, Heidrich G. Management of pain during debridement: A survey of US burn units. Pain. 1982;13:267–280
  19. Portenoy R. Chronic opioid therapy in non malignant pain. J Pain Symptom Manage. 1990;5(Supplement):S46–S62
  20. Porter J, Jick H. Addiction rate in patients treated with narcotics. N Engl J Med. 1980;302:123
  21. Reid M, Engles-Horton L, Weber M, Kerns R, Rogers E. Use of opioid medications for chronic non cancer pain syndrome in primary care. J Gen Intern Med. 2002;17:173–179
  22. Savage S. Long-term opioid therapy: Assessment of consequences and risks. J Pain Symptom Manage. 1996;11:274–286
  23. Stewart W, Ricci J, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443–2454
  24. Substance Abuse and Mental health Services Administration (SAMHSA) Office of Applied Studies. Results from the 2005 National Survey on Drug Use and Health: National Findings. http://www.oas.samhsa.gov/nsduh.htm. Pages 71-75.
  25. Waisman D, Haddox J. Opioid pseudo addiction: An iatrogenic syndrome. J Pain Symptom Manage. 2000;19:274–286
  26. Webster L, Webster R. Predicting aberrant behaviors in opioid treated patients: Preliminary validation of the opioid risk tool. Pain Med. 2005;6:432–438
  27. Wilson P. Opioid use and diversion: report on recent hearing by FDA and DEA: ASA statement to FDA committee. ASA Newsletter. 2002;66:9–10

 This study was supported by NIDA grant R01 DA013686. There were no pharmaceutical resources used in this study. None of the authors received consultation fees or have investments in pharmaceutical companies.

PII: S1526-5900(07)00630-X

doi: 10.1016/j.jpain.2007.02.432

The Journal of Pain
Volume 8, Issue 7 , Pages 573-582 , July 2007

Article Tools